The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnexo Group Plc Regulatory News (ANX)

Share Price Information for Anexo Group Plc (ANX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.50
Bid: 64.00
Ask: 65.00
Change: -0.50 (-0.77%)
Spread: 1.00 (1.563%)
Open: 64.50
High: 64.50
Low: 64.50
Prev. Close: 65.00
ANX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Anexo Group PLC - Further Amendment

25 Jun 2021 08:41

Form 8.3 - Anexo Group PLC - Further Amendment

FORM 8.3

AMENDMENT – FURTHER CHANGE TO SECTION 2

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Downing LLP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.Downing Strategic Micro Cap Investment Trust Plc
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeAnexo Group plc (ISIN GB00BF2G3L29)
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:n/a
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure23.06.21
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:    
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:0000

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
OrdinarySale1,203,875£1. 44134980791

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
None    

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
None       

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
None    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:24.06.2021
Contact name:Grant Whitehouse
Telephone number*:0207 416 7780

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
25th Apr 20247:00 amRNSAppointment of CFO and Notice of Results
2nd Apr 20247:00 amRNSSupreme Court Judgment on Damages for Injuries
21st Feb 20247:00 amRNSDirector/PDMR Shareholding
19th Feb 20247:00 amRNSDirector/PDMR Shareholding
16th Feb 20247:00 amRNSSuccessful Supreme Court Appeal
14th Feb 20247:00 amRNSDirector/PDMR Shareholding
7th Feb 20247:00 amRNSThirlwall Inquiry and Covid Action
1st Feb 20247:00 amRNSFY2023 Trading Update & Update on Emissions Claims
22nd Aug 20237:01 amRNSInterim Results for the six months ended 30/06/23
22nd Aug 20237:00 amRNSDirectorate Change
1st Aug 20237:00 amRNSInvestor Presentation via Investor Meet Company
31st Jul 20237:00 amRNSNotice of Interim Results
18th Jul 20237:00 amRNSLandmark Appeal Success on Recovery of Costs
20th Jun 20237:00 amRNSDirectorate Change
15th Jun 202312:07 pmRNSAnnual General Meeting
5th Jun 20233:30 pmRNSSettlement with Volkswagen AG
23rd May 20237:00 amRNSAnnual Report & Accounts, Notice of AGM
10th May 20237:00 amRNSFinal Results
4th May 20237:00 amRNSNotice of Analyst Presentation
18th Apr 20234:58 pmRNSDirectorate Change
14th Apr 20234:31 pmRNSUpdate on Mercedes Action & Directorate Change
12th Apr 20237:00 amRNSNotice of Results Amendment
4th Apr 20237:00 amRNSPre-Close Trading Update & Mercedes Class Action
7th Feb 20237:00 amRNSChange of Adviser and Trading Update
25th Oct 20227:00 amRNSDirector/PDMR Shareholding
20th Sep 20227:00 amRNSInterim Results
26th Aug 20227:00 amRNSAppointment of Director & Notice of Interim Result
3rd Aug 20222:28 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSDirectorate Change
16th Jun 202212:07 pmRNSResult of Annual General Meeting
16th Jun 20227:00 amRNSAGM Trading Update
26th May 20227:00 amRNSVolkswagen Emissions Case
25th May 20224:35 pmRNSPrice Monitoring Extension
24th May 20227:00 amRNSAnnual Report & Accounts and Notice of AGM
11th May 20227:00 amRNSBoard Changes
11th May 20227:00 amRNSFinal Results
27th Apr 20224:31 pmRNSAppointment of Nominated Adviser
7th Apr 20227:00 amRNSPre-Close Trading Statement
4th Apr 20227:00 amRNSIssue of shares pursuant to the MIP
8th Feb 202212:56 pmRNSSHARES MAGAZINE/AJ BELL Investor Event
18th Jan 20227:00 amRNSFY 2021 Trading Update
22nd Dec 20217:00 amRNSHigh Court Judgment re. Volkswagen
7th Dec 20217:00 amRNSEstablishment of Housing Disrepair Team
25th Nov 20217:00 amRNSMajor Claims Contract and Appointment of Director
13th Oct 20213:55 pmRNSForm 8.3 - Anexo Group Plc - Replacement
13th Oct 20213:11 pmRNSForm 8.3 - Anexo Group Plc
30th Sep 20217:00 amRNSIncrease in Debt Facilities to Fund Growth
13th Sep 20217:00 amRNSInterim Results
18th Aug 20214:49 pmRNSStatement regarding DBAY Advisors Limited
18th Aug 20214:45 pmRNSStatement re possible offer for Anexo Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.